What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Tuberculosis
Sven Hoffner spends much of his time researching Mycobacterium tuberculosis, Tuberculosis, Microbiology, Drug resistance and Internal medicine.
Sven Hoffner is involved in the study of Mycobacterium tuberculosis that focuses on Pyrazinamide in particular.
His work deals with themes such as Global health and Genotype, which intersect with Tuberculosis.
As part of the same scientific family, Sven Hoffner usually focuses on Microbiology, concentrating on Isoniazid and intersecting with Minimum inhibitory concentration.
His work carried out in the field of Drug resistance brings together such families of science as Surgery, Rifampicin and Capreomycin.
His Internal medicine research is multidisciplinary, incorporating perspectives in Drug susceptibility, Sputum, Pharmacology and Oncology.
His most cited work include:
- A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. (1538 citations)
- Global trends in resistance to antituberculosis drugs. (576 citations)
- Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage (307 citations)
What are the main themes of his work throughout his whole career to date?
Sven Hoffner focuses on Mycobacterium tuberculosis, Tuberculosis, Microbiology, Drug resistance and Virology.
Pyrazinamide is the focus of his Mycobacterium tuberculosis research.
His Pyrazinamide research includes themes of Moxifloxacin, Ethionamide and Pharmacology.
Sven Hoffner has included themes like Internal medicine and Multiple drug resistance in his Tuberculosis study.
His Microbiology research incorporates themes from In vitro and Mycobacterium.
His Drug resistance research integrates issues from Immunology, Capreomycin, Rifampicin and Intensive care medicine.
He most often published in these fields:
- Mycobacterium tuberculosis (72.02%)
- Tuberculosis (64.68%)
- Microbiology (44.04%)
What were the highlights of his more recent work (between 2013-2021)?
- Mycobacterium tuberculosis (72.02%)
- Tuberculosis (64.68%)
- Drug resistance (37.16%)
In recent papers he was focusing on the following fields of study:
His main research concerns Mycobacterium tuberculosis, Tuberculosis, Drug resistance, Pyrazinamide and Internal medicine.
His Mycobacterium tuberculosis research incorporates elements of Genetics, Epidemiology, Virology, Microbiology and Genotype.
The Microbiology study combines topics in areas such as Bacilli and In vitro, Structure–activity relationship, Biochemistry.
His Tuberculosis study incorporates themes from Odds ratio, Multiple drug resistance, Cohort study, Infection control and Ofloxacin.
His Drug resistance research includes elements of Parasitology, Ethambutol, Rifampicin, Intensive care medicine and Drug.
His Pyrazinamide research focuses on subjects like Ethionamide, which are linked to Prothionamide.
Between 2013 and 2021, his most popular works were:
- Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage (307 citations)
- Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages (189 citations)
- A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis (166 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Tuberculosis
Sven Hoffner mostly deals with Mycobacterium tuberculosis, Pyrazinamide, Tuberculosis, Internal medicine and Pharmacology.
His Mycobacterium tuberculosis study combines topics from a wide range of disciplines, such as Lineage, Genome, Whole genome sequencing and Drug resistance, Microbiology.
His biological study spans a wide range of topics, including Rifampicin and Capreomycin.
His studies in Pyrazinamide integrate themes in fields like Moxifloxacin and Ethionamide.
His Tuberculosis study integrates concerns from other disciplines, such as Multiple drug resistance, Retrospective cohort study, Molecular epidemiology, Genotype and Family history.
The study incorporates disciplines such as Ofloxacin, Bedaquiline and Environmental health in addition to Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
